MayTech Global Investments LLC bought a new stake in Stryker Co. (NYSE:SYK) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 16,283 shares of the medical technology company’s stock, valued at approximately $2,521,000. Stryker accounts for 1.7% of MayTech Global Investments LLC’s investment portfolio, making the stock its 24th biggest holding.
Several other hedge funds and other institutional investors also recently made changes to their positions in SYK. Sawyer & Company Inc acquired a new stake in shares of Stryker in the fourth quarter valued at about $125,000. Sit Investment Associates Inc. grew its position in shares of Stryker by 114.3% in the fourth quarter. Sit Investment Associates Inc. now owns 825 shares of the medical technology company’s stock valued at $128,000 after purchasing an additional 440 shares during the period. San Francisco Sentry Investment Group CA grew its position in shares of Stryker by 47.8% in the third quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company’s stock valued at $143,000 after purchasing an additional 325 shares during the period. Oak Point Wealth Management purchased a new position in shares of Stryker in the fourth quarter worth about $145,000. Finally, Dubuque Bank & Trust Co. purchased a new position in shares of Stryker in the fourth quarter worth about $164,000. Institutional investors and hedge funds own 74.49% of the company’s stock.
In other Stryker news, VP William E. Berry, Jr. sold 1,306 shares of Stryker stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $164.42, for a total transaction of $214,732.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Graham A. Mclean sold 2,984 shares of Stryker stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $160.53, for a total transaction of $479,021.52. Following the sale, the insider now owns 9,100 shares of the company’s stock, valued at $1,460,823. The disclosure for this sale can be found here. Insiders have sold 16,840 shares of company stock worth $2,749,989 over the last ninety days. 7.40% of the stock is owned by insiders.
Stryker Co. (SYK) opened at $161.70 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.59 and a current ratio of 2.29. Stryker Co. has a 52 week low of $127.19 and a 52 week high of $170.00. The company has a market cap of $60,579.61, a PE ratio of 60.34, a price-to-earnings-growth ratio of 2.32 and a beta of 0.70.
Stryker (NYSE:SYK) last issued its earnings results on Tuesday, January 30th. The medical technology company reported $1.96 EPS for the quarter, topping analysts’ consensus estimates of $1.95 by $0.01. Stryker had a net margin of 8.20% and a return on equity of 24.56%. The company had revenue of $3.47 billion for the quarter, compared to the consensus estimate of $3.42 billion. During the same period in the previous year, the firm earned $1.78 earnings per share. Stryker’s quarterly revenue was up 9.9% compared to the same quarter last year. equities analysts predict that Stryker Co. will post 7.12 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, April 30th. Shareholders of record on Thursday, March 29th will be paid a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date of this dividend is Wednesday, March 28th. Stryker’s dividend payout ratio (DPR) is presently 70.15%.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.